Research Analysts Offer Predictions for TriMas Q2 Earnings

TriMas Co. (NASDAQ:TRS) – Equities researchers at Zacks Research lowered their Q2 2025 EPS estimates for TriMas in a research note issued to investors on Monday, March 10th. Zacks Research analyst M. Das now forecasts that the industrial products company will earn $0.49 per share for the quarter, down from their prior estimate of $0.54. The consensus estimate for TriMas’ current full-year earnings is $1.69 per share. Zacks Research also issued estimates for TriMas’ Q3 2025 earnings at $0.54 EPS, Q4 2025 earnings at $0.36 EPS, FY2025 earnings at $1.82 EPS, Q2 2026 earnings at $0.54 EPS and Q3 2026 earnings at $0.59 EPS.

Separately, BWS Financial reaffirmed a “buy” rating and set a $40.00 price objective on shares of TriMas in a research report on Friday, February 28th.

TriMas Stock Performance

Shares of TRS stock opened at $23.99 on Thursday. The firm has a market cap of $973.59 million, a P/E ratio of 37.48 and a beta of 0.65. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44. TriMas has a fifty-two week low of $19.33 and a fifty-two week high of $28.51. The stock’s 50-day moving average is $23.56 and its two-hundred day moving average is $25.05.

TriMas Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 28th were given a $0.04 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.67%. TriMas’s dividend payout ratio is currently 27.12%.

Insiders Place Their Bets

In other news, Director Jeffrey A. Fielkow bought 2,500 shares of the company’s stock in a transaction that occurred on Friday, February 28th. The shares were purchased at an average price of $20.78 per share, for a total transaction of $51,950.00. Following the acquisition, the director now directly owns 11,013 shares of the company’s stock, valued at $228,850.14. The trade was a 29.37 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Shawn Sedaghat bought 554,149 shares of the business’s stock in a transaction on Monday, March 10th. The shares were purchased at an average cost of $24.07 per share, with a total value of $13,338,366.43. Following the transaction, the director now owns 900,974 shares in the company, valued at approximately $21,686,444.18. The trade was a 159.78 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 806,246 shares of company stock valued at $19,338,213 over the last quarter. Insiders own 1.10% of the company’s stock.

Institutional Trading of TriMas

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. FMR LLC increased its position in TriMas by 1.7% in the 3rd quarter. FMR LLC now owns 44,082 shares of the industrial products company’s stock worth $1,125,000 after buying an additional 729 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in TriMas by 3.7% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,106 shares of the industrial products company’s stock worth $568,000 after buying an additional 834 shares during the period. Sterling Capital Management LLC increased its position in TriMas by 815.5% in the 4th quarter. Sterling Capital Management LLC now owns 1,300 shares of the industrial products company’s stock worth $32,000 after buying an additional 1,158 shares during the period. JPMorgan Chase & Co. grew its position in TriMas by 3.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 38,461 shares of the industrial products company’s stock worth $982,000 after purchasing an additional 1,227 shares during the last quarter. Finally, MetLife Investment Management LLC increased its holdings in shares of TriMas by 5.9% during the 4th quarter. MetLife Investment Management LLC now owns 24,788 shares of the industrial products company’s stock worth $610,000 after purchasing an additional 1,378 shares during the period. Institutional investors and hedge funds own 99.42% of the company’s stock.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.